• Study Comparing Venetoclax and Obinutuzumab with Drug Combination for Fit Patients with Untreated Chronic Lymphocytic Leukemia Without Specific Genetic Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study of Sasanlimab Treatment as a Bladder-Sparing Strategy in Patients with Muscle Invasive Bladder Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    Spain

  • Study on Darolutamide with Standard Therapy for Patients with High-Risk Localized Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland

  • Long-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Norway Spain

  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia France Germany Hungary Ireland +6

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy Spain

  • Study of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal Romania Spain

  • Study on Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to Current Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

powered by